Abstract:Sirtuins (SIRT1-SIRT7), a family of nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-dependent enzymes, are key regulators of life span and metabolism. In addition to acting as deacetylates, some sirtuins have the properties of deacylase, decrotonylase, adenosine diphosphate (ADP)-ribosyltransferase, lipoamidase, desuccinylase, demalonylase, deglutarylase, and demyristolyase. Mitochondrial dysfunction occurs early on and acts causally in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). Sirtuins are implicated in the regulation of mitochondrial quality control, which is highly associated with the pathogenesis of neurodegenerative diseases. There is growing evidence indicating that sirtuins are promising and well-documented molecular targets for the treatment of mitochondrial dysfunction and neurodegenerative disorders by regulating mitochondrial quality control, including mitochondrial biogenesis, mitophagy, mitochondrial fission/fusion dynamics, and mitochondrial unfolded protein responses (mtUPR). Therefore, elucidation of the molecular etiology of sirtuin-mediated mitochondrial quality control points to new prospects for the treatment of neurodegenerative diseases. However, the mechanisms underlying sirtuin-mediated mitochondrial quality control remain obscure. In this review, we update and summarize the current understanding of the structure, function, and regulation of sirtuins with an emphasis on the cumulative and putative effects of sirtuins on mitochondrial biology and neurodegenerative diseases, particularly their roles in mitochondrial quality control. In addition, we outline the potential therapeutic applications for neurodegenerative diseases of targeting sirtuin-mediated mitochondrial quality control through exercise training, calorie restriction, and sirtuin modulators in neurodegenerative diseases.

Sirtuins in clinical trials of approaches to the treatment of neurodegenerative diseases

The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

The influential responsibility of sirtuins in senescence and associated diseases: A review

Activation and inhibition of sirtuins: From bench to bedside

Research progress on Sirtuins (SIRTs) family modulators

A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research

Sirtuins and Their Biological Relevance in Aging and Age-Related Diseases.

Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators

Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?

Current Trends in Sirtuin Activator and Inhibitor Development

Research progress of sirtuins in renal and cardiovascular diseases.

Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing

SIRT1, resveratrol and aging

Sirtuin 1 as a potential molecular target of resveratrol in selected diseases

Role of Sirtuins in Physiology and Diseases of the Central Nervous System

Sirtuins at the Service of Healthy Longevity

Protective Effects and Mechanisms of Sirtuins in the Nervous System

The beneficial role of SIRT1 in preventive or therapeutic options of Neurodegenerative Diseases

Sirtuins in kidney diseases: potential mechanism and therapeutic targets

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target